Advertisement

Topics

As Products With Marijuana Extract Flood The Market, FDA Left Scrambling To Keep Up

08:25 EDT 26 Mar 2019 | Kaiser Health News

Minutes after the farm bill, which legalized hemp in certain circumstances, was signed in December, the FDA asserted that it could police the market because it had already approved a CBD-based medicine — and could subject other products to the same strict standards. But lawmakers say the agency is just creating trouble for itself. Meanwhile, new research shows that edibles could be responsible for an increase in cannabis-triggered emergency room visits.

Original Article: As Products With Marijuana Extract Flood The Market, FDA Left Scrambling To Keep Up

NEXT ARTICLE

More From BioPortfolio on "As Products With Marijuana Extract Flood The Market, FDA Left Scrambling To Keep Up"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...